Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Br J Biomed Sci ; 62(2): 71-6, 2005.
Article in English | MEDLINE | ID: mdl-15997880

ABSTRACT

Maternal diabetes is associated with an increased rate of congenital fetal anomaly. In the present study, diabetes was induced by streptozotocin in female rats one week prior to conception and the embryos were examined during organogenesis. Experimental diabetes is associated with over-production of free radicals and disturbed antioxidant defence, particularly in malformed embryos. Oxidative stress is demonstrated by increased MDA accumulation and reduced glutathione levels. Despite large differences in the reduced/oxidised glutathione ratios during organogenesis in the control, diabetic non-malformed and malformed embryo groups, the half-cell redox potential was constant for each group during the experimental period. Calculated redox potentials indicated that although embryo cells from the control and diabetic mother groups were of the same chronological age, the stages of development were different. Increased oxidative stress in rat embryos was associated with increased glutathione peroxidases and glutathione-S-transferase activity. This may, in part, provide an explanation for the observed accumulation of oxidised glutathione in malformed embryos. Moreover, decreased levels of vitamin C and selenium were observed. Increased oxidative stress and perturbations in antioxidant defence contribute to the high incidence of congenital anomalies in experimental diabetic gestation.


Subject(s)
Antioxidants/metabolism , Congenital Abnormalities/etiology , Diabetes Mellitus, Experimental/metabolism , Oxidative Stress/physiology , Pregnancy in Diabetics/metabolism , Animals , Ascorbic Acid/analysis , Congenital Abnormalities/metabolism , Female , Fetal Development/physiology , Glutathione/metabolism , Pregnancy , Rats , Rats, Wistar , Reactive Oxygen Species/metabolism , Selenium/analysis
2.
Br J Biomed Sci ; 62(4): 161-5, 2005.
Article in English | MEDLINE | ID: mdl-16411374

ABSTRACT

The causes of, and predisposing conditions for, increased congenital anomalies in embryos of experimental diabetic gestation are not fully identified. In the present study, some possible factors involved in diabetes-induced embryopathy are explored. The concentration of PGE2, the gene expression of cyclooxygenases (COX-1 and COX-2) and level of apoptosis (measured by caspase-3 activity) are assessed during organogenesis in the embryos of streptozotocin-induced diabetic rats. The concentrations of PGE2 in the embryos of diabetic rats were lower than controls, with the lowest values in malformed embryos and their associated membranes (yolk sacs). The pattern of change in PGE2 was similar in the embryos of the control and diabetic groups, which showed a steady decline between days 9 and 11 of gestation. These changes in PGE2 were accompanied by a small decrease in COX-1 expression in all embryos and associated membranes during the same gestational period. Expression of COX-2, which was below normal in diabetic embryos, decreased between days 9 and 11 of gestation in all groups. In the membranes of non-malformed embryos, COX-2 expression peaked on day 10 of gestation. It was found that there was little or no detectable COX-2 expression in the membranes of malformed embryos on day 9 of gestation and although its expression was detectable on the following days it was much lower than in the other groups. Caspase-3 activity increased substantially between days 9 and 11 of gestation. Embryos from the experimentally diabetic group showed higher activity than did controls, with the largest increases in the malformed embryos. It would appear that COX-2 expression and PGE2 concentration (in both embryo and associated membranes) play a significant role in organ formation. The data presented here suggest that an unhealthy placenta may be instrumental in the development of malformed embryos.


Subject(s)
Diabetes Mellitus, Experimental/metabolism , Dinoprostone/metabolism , Fetus/abnormalities , Pregnancy in Diabetics/metabolism , Prostaglandin-Endoperoxide Synthases/metabolism , Animals , Apoptosis , Female , Fetal Development , Fetus/metabolism , Pregnancy , Rats , Rats, Wistar
3.
Trop Med Int Health ; 3(9): 721-7, 1998 Sep.
Article in English | MEDLINE | ID: mdl-9754667

ABSTRACT

We performed a series of ELISAs to evaluate the diagnostic significance of two Schistosoma mansoni proteins, Sm31 (cysteine proteinase, cathepsin B) and Sm32 (asparaginyl endopeptidase). Our study populations were chosen from two villages in an endemic area close to Alexandria. Using fusion proteins MS2-Sm31 and MS2-Sm32 as antigens, 70% and 78.9%, respectively, of patient sera from 134 parasitologically confirmed cases reacted positively. The percentage of seropositivity increased to 84.5% when parasite-derived proteins Sm31 and Sm32 were used. The serum levels of antibodies to these two proteins in recombinant or native forms do not correlate with intensity of infection and hence are detected even when egg counts are low, which makes proteins Sm31 and Sm32 useful antigens in the identification of S. mansoni infected cases, particularly in endemic areas in Egypt.


Subject(s)
Antibodies, Helminth/blood , Antigens, Helminth/immunology , Cysteine Endopeptidases/immunology , Endemic Diseases , Helminth Proteins/immunology , Plant Proteins , Schistosoma mansoni/immunology , Schistosomiasis mansoni/diagnosis , Schistosomiasis mansoni/immunology , Adolescent , Adult , Animals , Case-Control Studies , Child , Child, Preschool , Egypt/epidemiology , Enzyme-Linked Immunosorbent Assay , Feces/parasitology , Female , Humans , Male , Middle Aged , Parasite Egg Count , Reproducibility of Results , Schistosomiasis mansoni/epidemiology , Sensitivity and Specificity , Seroepidemiologic Studies , Severity of Illness Index
4.
Acta Biol Med Ger ; 41(5): 451-6, 1982.
Article in English | MEDLINE | ID: mdl-6182711

ABSTRACT

This study has been carried out by measuring the cholinesterase (ChE) activity in blood serum and in some organs (brain, liver, spleen, kidney, small intestine, lung, and cardiac muscle) of rats before and at different time intervals after infusion of 65 dextran 70, and 5% gelatin 40 solutions (1 ml/100 g body weight). The controls received infusions of the diluent of the gelatin preparation. The data obtained showed that the infusion of the diluent in rats has no effect on ChE activity neither in blood serum nor in other organs at any time intervals after infusion. In case of dextran and gelatin, a significant increase in ChE activity in blood serum and the tested organs was observed at different time intervals after infusion. The increase in case of dextran was more marked than in case of gelatin. These measurements returned to base-line values during 72 h after infusion. Furthermore, the study failed to disclose any untoward reactions, either immediate or delayed, which could be attributed to the infusion solutions.


Subject(s)
Cholinesterases/metabolism , Dextrans/pharmacology , Gelatin/pharmacology , Animals , Brain/enzymology , Cholinesterases/blood , Intestine, Small/enzymology , Kidney/enzymology , Liver/enzymology , Lung/enzymology , Male , Myocardium/enzymology , Rats , Spleen/enzymology
SELECTION OF CITATIONS
SEARCH DETAIL
...